10.69 USD
+0.12 (+1.14%)
AT CLOSE (11:59 AM EDT)
MiNK Therapeutics, Inc. Common Stock (INKT)
NASDAQ: INKT • USD
10.55
-0.08 (-0.75%)
POST MARKET (AS OF 04:13 PM EDT)
Market: OPEN
Open?$10.47
High?$10.73
Low?$10.24
Prev. Close?$10.57
Volume?35.5K
Avg. Volume?587.3K
VWAP?$10.44
Rel. Volume?0.06x
Bid / Ask
Bid?$10.53 × 100
Ask?$11.90 × 100
Spread?$1.37
Midpoint?$11.22
Valuation & Ratios
Market Cap?49.6M
Shares Out?4.7M
Float?1.2M
Float %?24.8%
P/E Ratio?N/A
P/B Ratio?-3.49
EPS?-$2.66
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.06Adequate
Quick Ratio?1.06Adequate
Cash Ratio?1.03Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?-3.49CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.9CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?87.8%STRONG▾
ROA?-87.8%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$36.3M
Related Companies
Loading...
News
Profile
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
Employees
23
Market Cap
49.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-10-15
Address
149 FIFTH AVENUE
NEW YORK, NY 10010
Phone: 212-994-8250
NEW YORK, NY 10010
Phone: 212-994-8250